- Amended Statement of Beneficial Ownership (SC 13D/A)
21 Julho 2009 - 6:11PM
Edgar (US Regulatory)
|
|
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
|
OMB
APPROVAL
|
|
|
OMB
Number: 3235-0145
Expires:
February 28, 2009
Estimated
average burden
hours
per response....... 14.5
|
SCHEDULE
13D
Under
the Securities Exchange Act of 1934
Orbotech
Ltd.
(Name of
Issuer)
Ordinary
Shares (NIS 0.14 nominal par value)
(Title of
Class of Securities)
M75253100
(CUSIP
Number)
Richard
Hall, Esq.
Cravath,
Swaine & Moore LLP
Worldwide
Plaza
825
Eighth Avenue
New
York, NY 10019
(212)
474-1000
(Name,
Address and Telephone Number of Person
Authorized
to Receive Notices and Communications)
July
20, 2009
(Date of
Event which Requires Filing of this Statement)
If the
filing person has previously filed a statement on Schedule 13G to report the
acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box [ ].
NOTE:
Schedules filed in paper format shall include a signed original and five copies
of the schedule, including all exhibits. See Section 240.13d-7 for
other parties to whom copies are to be sent.
*The
remainder of this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The
information required on the remainder of this cover page shall not be deemed to
be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the
Notes).
Persons
who respond to the collection of information contained in this form are
not
required
to respond unless the form displays a currently valid OMB control
number.
CUSIP No.
M75253100
|
1.
|
Names
of Reporting Persons.
I.R.S.
Identification Nos. of above persons (entities only).
Dr.
Jacob Richter
|
|
2.
|
Check
the Appropriate Box if a Member of a Group (See Instructions)
(a) [
X
]
(b) [
]
|
|
3.
|
SEC
Use Only
|
|
4.
|
Source
of Funds (See Instructions)
PF
|
|
5.
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or
2(e)
[
]
|
|
6.
|
Citizenship
or Place of Organization
Israel
|
|
|
|
|
Number
of
Shares
Bene
ficially
Owned
by
Each
Reporting
Person
With
|
7. Sole
Voting Power
0
|
|
8. Shared
Voting Power
3,033,945
|
|
9. Sole
Dispositive Power
0
|
|
10. Shared
Dispositive Power
3,033,945
|
|
11.
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
3,033,945
|
|
12.
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See
Instructions)
[
]
|
|
13.
|
Percent
of Class Represented by Amount in Row (11)
|
|
14.
|
Type
of Reporting Person (See Instructions)
IN
|
1
Based on
34,106,775 Ordinary Shares of the Issuer, as reported in the Issuer’s Form 20-F,
filed with the Securities and Exchange Commission on March 27,
2009.
CUSIP No.
M75253100
|
1.
|
Names
of Reporting Persons.
I.R.S.
Identification Nos. of above persons (entities only).
Dr.
Judith Richter
|
|
2.
|
Check
the Appropriate Box if a Member of a Group (See Instructions)
(a) [
X
]
(b) [
]
|
|
3.
|
SEC
Use Only
|
|
4.
|
Source
of Funds (See Instructions)
PF
|
|
5.
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or
2(e)
[
]
|
|
6.
|
Citizenship
or Place of Organization
Israel
|
|
|
|
|
Number
of
Shares
Bene
ficially
Owned
by
Each
Reporting
Person
With
|
7. Sole
Voting Power
0
|
|
8. Shared
Voting Power
3,033,945
|
|
9. Sole
Dispositive Power
0
|
|
10. Shared
Dispositive Power
3,033,945
|
|
11.
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
3,033,945
|
|
12.
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See
Instructions)
[
]
|
|
13.
|
Percent
of Class Represented by Amount in Row (11)
|
|
14.
|
Type
of Reporting Person (See Instructions)
IN
|
2
Based on
34,106,775 Ordinary Shares of the Issuer, as reported in the Issuer’s Form 20-F,
filed with the Securities and Exchange Commission on March 27,
2009.
Schedule
13D
This
Amendment No. 1 amends the original Schedule 13D (the “Original Schedule 13D”)
filed with the Securities and Exchange Commission by each of Dr. Jacob Richter
and Dr. Judith Richter (the “Reporting Persons”) on July 14,
2009. This Amendment No. 1 is being filed as a result of the
information disclosed in Items 3 and 5 below.
Item
3. Source and Amount of Funds or Other Consideration
Item 3 of
the Original Schedule 13D is hereby amended and restated in its entirety as
follows:
On July
7, 2009 the Reporting Persons purchased 1,200,000 shares of Ordinary Shares in
privately negotiated transactions at an aggregate purchase price (excluding
trading commissions and related administrative costs) of
$12,000,000. The source of the funds used by the Reporting Persons to
purchase such shares was personal funds of the Reporting Persons.
On July
20, 2009 the Reporting Persons purchased 418,500 shares of Ordinary Shares in a
privately negotiated transaction at an aggregate purchase price (excluding
trading commissions and related administrative costs) of
$4,185,000. The source of the funds used by the Reporting Persons to
purchase such shares was personal funds of the Reporting Persons.
Item
5. Interest in Securities of the Issuer
Item 5 of
the Original Schedule 13D is hereby amended and restated in its entirety as
follows:
(a) Items
(11) and (13) of the cover pages of this Schedule 13D are hereby incorporated by
reference.
(b) Items
(7) through (10) of the cover pages of this Schedule 13D are hereby incorporated
by reference.
(c) See
Annex A
hereto.
(d) Not
applicable.
(e) Not
applicable.
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement is true, complete and
correct.
|
/s/ Jacob Richter
|
|
Dr. Jacob Richter
|
|
/s/ Judith Richter
|
|
Dr. Judith
Richter
|
July 21, 2009
Annex
A
The table
below sets forth purchases of the Ordinary Shares by the Reporting Persons
during the last 60 days. All such purchases were effected by the
Reporting Persons in privately negotiated transactions.
|
Date
|
Reporting
Person who
effected
the purchase
|
Amount
of Shares
|
Price
Per Share ($)
(net
of commissions)
|
|
July
7, 2009
|
Dr.
Jacob Richter and Dr. Judith Richter
|
1,200,000
|
$10.00
|
|
July
20, 2009
|
Dr.
Jacob Richter and Dr. Judith Richter
|
418,500
|
$10.00
|
7
Orbotech Ltd. - Ordinary Shares (NASDAQ:ORBK)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Orbotech Ltd. - Ordinary Shares (NASDAQ:ORBK)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre Orbotech Ltd. - Ordinary Shares da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de